Strategy of Anti-Platelet Therapy after PCI in High-Risk Patients
[Speaker] Jee Hoon Kang/Seoul National Univ., Korea
Rivaroxaban and the Future of SPAF in Patients of AF
[Speaker] Pil-Sung Yang/Cha Univ., Korea